Izumi N, Tokumaru Y, Kondo H
Jpn J Med Sci Biol. 1983 Apr;36(2):75-83. doi: 10.7883/yoken1952.36.75.
To re-evaluate the current potency tests of C. oedematiens anti-toxin that titrates only the anti-lethal activity in mice, investigations were made on neutralization of the lethal, edematizing, and hemolytic activities with different preparations of the antitoxin and on their therapeutic effects. The anti-lethal and anti-edematizing potencies of antitoxins prepared by hyperimmunization with each of crude and purified antigens were the same when titrated with either crude or purified lethal toxin as test toxin. The two antitoxins protected mice equally against the lethal and edematizing activities of crude toxin. The antitoxin prepared against highly purified hemolytic toxin contained neither anti-lethal nor anti-edematizing activity. We conclude that the lethal and edematizing activities of C. oedematiens. are borne by the same molecule and that the therapeutic effect of the antitoxin may depend entirely on the anti-lethal (or anti-edematizing) activity. The method currently used for titrating C. oedematiens antitoxin, therefore, appears to be valid.
为了重新评估目前仅滴定小鼠抗致死活性的水肿梭菌抗毒素效价检测方法,对不同制剂抗毒素对致死、水肿和溶血活性的中和作用及其治疗效果进行了研究。用粗制和纯化抗原分别进行超免疫制备的抗毒素,以粗制或纯化致死毒素作为检测毒素进行滴定时,其抗致死和抗水肿效价相同。这两种抗毒素对小鼠抵御粗制毒素的致死和水肿活性具有同等保护作用。针对高度纯化溶血毒素制备的抗毒素既无抗致死活性也无抗水肿活性。我们得出结论,水肿梭菌的致死和水肿活性由同一分子承载,抗毒素的治疗效果可能完全取决于抗致死(或抗水肿)活性。因此,目前用于滴定水肿梭菌抗毒素的方法似乎是有效的。